Human CIITA CRISPR gRNA in Lenti Particles
This is a Class II, Major Histocompatibility Complex, Transactivator plasmid with gRNA insert cloned into Lentiviral VectorpLenti-U6-sgRNA-PGK-Neo. Insert length: not_set. Stable, Transient expression. Suitable for PExp and GEEN.
Bacterial selection: Ampicillin.
Catalog No. ABIN5086464
$693.75
Plus shipping costs $50.00, if applicable $20.00 dry ice
300 μL
Shipping to:
United States
Delivery in 31 to 42 Business Days
Quick Overview for Human CIITA CRISPR gRNA in Lenti Particles (ABIN5086464)
Gene
CIITA
(Class II, Major Histocompatibility Complex, Transactivator (CIITA))
Application
Protein Expression (PExp), Genome Editing with Engineered Nucleases (GEEN)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Individual gRNA against CIITA in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- Sequence available upon placing order
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with an individual gRNA (300 μL) for a specific sequence of CIITA
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- CIITA (Class II, Major Histocompatibility Complex, Transactivator (CIITA))
-
Alternative Name
- CIITA
-
NCBI Accession
- NM_000246
Target
-
You are here:
